English Abstract
Journal Article
Add like
Add dislike
Add to saved papers

[Inverse correlation between psychotic disorders and tumor development].

Patients suffering from psychotic disorders have an increased morbidity compared with control population. Moreover, these patients are prone to habits such as smoking or obesity, which in fact are risk factors for developing neoplasias.

OBJECTIVE: The current study is aimed to determine the prevalence of oncologic processes (lung, colon and prostate cancer) among patients diagnosed with psychotic disorders.

METHODS: A total of 365 patients from the Hospital Universitario Fundación Alcorcón (HUFA) were included in the study. All of them were diagnosed with a psychotic disorder from 2013 to 2016.

RESULTS: Studying the prevalence of oncologic processes (lung, colon and prostate cancer) between both groups revealed a significant reduction in patients diagnosed with a psychotic disorder compared with the control populations (p-value <0,05).

CONCLUSIONS: Even though patients diagnosed with a psychotic disorder have a considerable morbidity and several risk factors related with the development of neoplasias, we can conclude that these patients are less likely to suffer from the aforementioned types of cancer.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app